Allergan announces presentations at the ARVO annual meeting

Allergan today announced its schedule of presentations at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting.

The meeting will be held in Seattle, Washington from May 1-5 at the Washington State Convention Center.

"Allergan is pleased to be presenting data at ARVO this year," EVP and President of Global R&D Brands David Nicholson said. "With more than 60 years of eye care experience and 17 mid-to-late stage programs in development, Allergan is committed to advancing research and products for the eye care community."

The 18 presentations range from studies on self-reported vision impairment in nursing home residents, to comparisons of gel-type artificial tears, to glaucoma therapies. The data is grouped into three categories: retina, ocular surface and glaucoma studies.

Allergan is a global leader in eye care products and medications. It also markets treatments for a wide range of other health-related conditions, including the cardiovascular system, central nervous system, urology and women's health. It is focused on developing and manufacturing prescription and generic drugs, biologics and over-the-counter medications. Allergan conducts commercial operations in approximately 100 countries.


Want to get notified whenever we write about Allergan, Inc. ?
Next time we write about Allergan, Inc., we'll email you a link to the story. You may edit your settings or unsubscribe at any time.
Organizations in this story

Allergan, Inc. 400 Interpace Pkwy Parsippany, NJ - 07054-1116